γ-Glutamylamines and neurodegenerative diseases.
Thomas M Jeitner, Kevin Battaile, Arthur J L Cooper
Index: Amino Acids 44(1) , 129-42, (2013)
Full Text: HTML
Abstract
Transglutaminases catalyze the formation of γ-glutamylamines utilizing glutamyl residues and amine-bearing compounds such as lysyl residues and polyamines. These γ-glutamylamines can be released from proteins by proteases in an intact form. The free γ-glutamylamines can be catabolized to 5-oxo-L-proline and the free amine by γ-glutamylamine cyclotransferase. Free γ-glutamylamines, however, accumulate in the CSF and affected areas of Huntington Disease brain. This observation suggests transglutaminase-derived γ-glutamylamines may play a more significant role in neurodegeneration than previously thought. The following monograph reviews the metabolism of γ-glutamylamines and examines the possibility that these species contribute to neurodegeneration.
Related Compounds
Related Articles:
2009-01-01
[Int. J. Food Sci. Nutr. 60 Suppl 7 , 99-108, (2009)]
2004-11-12
[J. Biol. Chem. 279(46) , 47754-62, (2004)]
2005-04-20
[J. Agric. Food Chem. 53(8) , 2830-7, (2005)]
2004-06-15
[Transplantation 77(11) , 1667-75, (2004)]
2011-12-01
[Eur. J. Oral Sci. 119 Suppl 1 , 50-4, (2011)]